Effects of Rehabilitation in Patients With Stable Chronic Heart Failure
Functional Characterization of Respiratory Muscles and Effects of Rehabilitation in Patients With Stable Chronic Heart Failure
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
Heart failure (HF) is a major public health problem. This is the first cause of hospitalization and mortality of about 65 years old. This syndrome is characterized by a poor prognosis and a high cost of care. Thus, new strategies for treatment and prevention of the HF are among the major challenges facing health sciences today. The management of HF requires multimodal approach it involves a combination of non-pharmacological and pharmacological treatment, Besides improvements in pharmacological treatment, supervised exercise programs are recommended for all patients with HF as part of a non-pharmacological management but many questions regarding exercise training in HF patients remain unanswered. Even simple questions such as the best mode of training for these patients are unclear. The aim of this study
- 1.First, to characterize the physiological functions involved in the genesis of exercise intolerance and dyspnea especially muscle function (respiratory and skeletal), and cardiopulmonary patients suffering from chronic HF.
- 2.Second, to study and compare the effects of different rehabilitation programs and prove the superiority of the combination of three training modalities program: aerobic training (AT), resistance training (RT) and inspiratory muscle training (IMT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started Jan 2015
Typical duration for not_applicable heart-failure
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
April 20, 2018
CompletedFirst Posted
Study publicly available on registry
May 29, 2018
CompletedMay 29, 2018
May 1, 2018
2.8 years
April 20, 2018
May 15, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Minnesota Living with Heart Failure Questionnaire (MLWHF)
The Quality of life was assessed using the Minnesota Living with Heart Failure Questionnaire (MLWHF). the minimum score is 0 and the maximum score is 105. the total score should decrease to indicate the amelioration of the quality of life.
Baseline and 12 weeks
Secondary Outcomes (12)
Change in Forced Vital Capacity (FVC)
Baseline and 12 weeks
Change in Forced Expiratory Muscle Volume in one second (FEV1)
Baseline and 12 weeks
Change in Left Ventricular Ejection Fraction (LVEF)
Baseline and 12 weeks
Change in Left Ventricular End Systolic and Diastolic Diameter (LVESD and LVEDD)
Baseline and 12 weeks
Change in Maximal Inspiratory Pressure (MIP)
Baseline and 12 weeks
- +7 more secondary outcomes
Study Arms (6)
Aerobic training
EXPERIMENTALPatients follow an alternating aerobic training using a treadmill at an intensity of 60% of maximum heart rate, 3 mn and 3 mn working off an alternative way.To ensure progressive overload appropriate, we adjust moderate intensity aerobic exercise every two weeks with an overall 5% increase in heart rate.
Inspiratory muscle training
EXPERIMENTALThe inspiratory muscle training involves a high intensity endurance training to 60% of PI, max. We recalculate the individual SPImax and PImax in each training session. Patients use the driving tool inspiratory muscle.
Resistance training
EXPERIMENTALThe resistance should be measured on 1 RM (Repetition Maximum) for each muscle group. The exercises are performed in three sets of ten repetitions of exercises at 60% of 1RM intensity recalculated every two weeks training.
Control
NO INTERVENTIONThe control group patients were allocated to a non-training time period, during which they were told to continue their life as before enrollment.
Aerobic and Inspiratory training
EXPERIMENTALNote that the Aerobic and Inspiratory group participant undergone same protocols of inspiratory and aerobic training stated above, with almost a 5 minutes rest in between.
Combined
EXPERIMENTALNote that the Aerobic, Inspiratory and resistance group participant undergone same protocols of inspiratory and aerobic training stated above, with almost a 5 minutes rest in between.
Interventions
Eligibility Criteria
You may qualify if:
- Congestive heart failure (CHF) due to ischemic or dilated cardiomyopathy.
- Left ejection fraction ≤ 45%.
- NYHA functional class II and III.
- A patient with a diagnosis of CHF for six months including no admission to the hospital or change in medications over the previous 3 months.
- IMW \<70% of predicted
You may not qualify if:
- Pulmonary limitation (forced expiratory volume in 1 s and/or vital capacity of less than 60% of predicted value).
- History of significant cardiac arrhythmia.
- History of myocardial infarction or cardiac surgery (6 months).
- Orthopedic or neurologic disease.
- Non echogenic, Unstable.
- Poorly controlled blood pressure.
- End-Stage HF (on the waiting list for transplantation or LVAD).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Sadek Z, Salami A, Youness M, Awada C, Hamade M, Joumaa WH, Ramadan W, Ahmaidi S. A randomized controlled trial of high-intensity interval training and inspiratory muscle training for chronic heart failure patients with inspiratory muscle weakness. Chronic Illn. 2022 Mar;18(1):140-154. doi: 10.1177/1742395320920700. Epub 2020 May 5.
PMID: 32370544DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- All evaluations were performed by investigators who were unaware of the allocation of patients to different interventions.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Physical Therapy Center
Study Record Dates
First Submitted
April 20, 2018
First Posted
May 29, 2018
Study Start
January 1, 2015
Primary Completion
October 15, 2017
Study Completion
January 1, 2018
Last Updated
May 29, 2018
Record last verified: 2018-05